These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 35400374

  • 1. Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica.
    El Chami S, Springer JM.
    Rheum Dis Clin North Am; 2022 May; 48(2):493-506. PubMed ID: 35400374
    [Abstract] [Full Text] [Related]

  • 2. Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica.
    El Chami S, Springer JM.
    Med Clin North Am; 2021 Mar; 105(2):311-324. PubMed ID: 33589105
    [Abstract] [Full Text] [Related]

  • 3. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
    Becker M.
    Praxis (Bern 1994); 2020 Mar; 109(5):347-354. PubMed ID: 32233763
    [Abstract] [Full Text] [Related]

  • 4. Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis.
    Man-Ger Sun M, Pope JE.
    Best Pract Res Clin Rheumatol; 2022 Dec; 36(4):101822. PubMed ID: 36907732
    [Abstract] [Full Text] [Related]

  • 5. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH.
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [Abstract] [Full Text] [Related]

  • 6. Giant cell arteritis and polymyalgia rheumatica: an update.
    González-Gay MA, Pina T.
    Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572
    [Abstract] [Full Text] [Related]

  • 7. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L, Spiera R.
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
    Salvarani C, Padoan R, Iorio L, Tomelleri A, Terrier B, Muratore F, Dasgupta B.
    Autoimmun Rev; 2024 Jan; 23(1):103415. PubMed ID: 37625672
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips.
    Mackie SL, Pease CT.
    Postgrad Med J; 2013 May; 89(1051):284-92. PubMed ID: 23355687
    [Abstract] [Full Text] [Related]

  • 15. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A.
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Giant Cell Arteritis and Polymyalgia Rheumatica: Treatment Approaches and New Targets.
    Nepal D, Putman M, Unizony S.
    Rheum Dis Clin North Am; 2023 Aug; 49(3):505-521. PubMed ID: 37331730
    [Abstract] [Full Text] [Related]

  • 18. Review of phase 2/3 trials in polymyalgia rheumatica and giant cell arteritis.
    Nageswaran P, Ahmed S, Tahir H.
    Expert Opin Emerg Drugs; 2024 Mar; 29(1):5-17. PubMed ID: 38180809
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.